Bruce et al. reported that HO-1 mRNA expression is significantly reduced in T2D patients [55], whereas upregulation of the HO system increases pancreatic β-cell insulin release and reduces hyperglycemia in different diabetic models [56]. This evidence concerns the gene HMOX1 and Hyperglycemia.